CD4 and COVID-19: To assess whether the predicted epitopes are recognized by COVID-19 infected patient T-cells, we tested the spike-S1, S2, and All-peptide mix on seven asymptomatic, five with mild-moderate symptoms, and five severe convalescent patients requiring ICU admission (Table S4) and analyzed their CD4 and CD8 T-cell response after 48 h.